News Release: July 27, 2025
(6-Aminohexyl)carbamic acid Price, Production, Latest News and Developments in 2025
(6-Aminohexyl)carbamic acid price trend and production News
(6-Aminohexyl)carbamic acid Price Trend in Past Five Years and Factors Impacting Price Movements
Over the past five years, the price trend of (6-Aminohexyl)carbamic acid has demonstrated moderate volatility, shaped by fluctuating raw material costs, shifts in global demand, regulatory changes, and supply chain constraints. From 2020 to 2024, the market showed a steady incline with occasional short-term dips due to market correction and global economic disruptions.
In 2020, the average price of (6-Aminohexyl)carbamic acid stood at approximately $2,200/MT. The pandemic-induced slowdown caused limited demand in pharmaceutical and chemical industries, leading to a temporary dip in production rates. However, the price held firm owing to limited inventory and constrained supply chains.
By 2021, prices began to rise gradually, averaging $2,350/MT. This surge was primarily attributed to recovery in the specialty chemicals sector and an uptick in downstream demand from pharmaceutical intermediates. Additionally, raw material cost increases, particularly for hexamethylene diamine, contributed to the uptick in pricing.
In 2022, prices witnessed further escalation, reaching around $2,520/MT. This was a result of improved export demand and regional production expansions in East Asia. The heightened regulatory focus on purity grades and environmental compliance in manufacturing facilities also led to increased operational costs, which were factored into the pricing.
By 2023, (6-Aminohexyl)carbamic acid price averaged around $2,780/MT. Supply chain normalization after COVID-19, combined with robust demand from the fine chemicals and biomedical segments, added upward pressure on pricing. Furthermore, export volumes to North America and Europe grew significantly, driven by increased acceptance of Asian formulations.
In 2024, the price crossed the $3,000/MT mark, averaging about $3,040/MT. A sharp rise in freight and logistics costs globally, alongside regional production restrictions during energy-intensive months, impacted the overall availability, leading to higher pricing across multiple markets. Environmental regulations in the European Union and China also caused temporary production halts, further tightening supply.
Factors such as raw material cost trends, regional policy changes, technological improvements in synthesis, and the rising cost of labor and utilities have all played significant roles in shaping the price trajectory of (6-Aminohexyl)carbamic acid. The push for higher-grade variants for biomedical applications has also placed pressure on producers to enhance purification processes, contributing to price increases.
(6-Aminohexyl)carbamic acid Price Trend Quarterly Update in $/MT
- Q1 2025: $3,100/MT
- Q2 2025: $3,180/MT
- Q3 2025 (Estimate): $3,250/MT
- Q4 2025 (Forecast): $3,300/MT
The trend for 2025 continues to show upward movement, fueled by consistent downstream demand and export growth. Rising production costs due to elevated energy prices and raw material import duties in some regions are expected to keep the prices bullish.
Global (6-Aminohexyl)carbamic acid Import-Export Business Overview
The global import-export scenario for (6-Aminohexyl)carbamic acid has evolved significantly in recent years, reflecting shifting production centers, policy influences, and changing global consumption patterns. With the compound gaining traction across pharmaceutical and specialty chemical domains, countries have intensified their engagement in international trade involving this compound.
Asia-Pacific remains the primary production hub, especially China, India, and South Korea, due to well-established chemical manufacturing infrastructure and access to raw materials. These countries not only fulfill domestic demand but also serve as leading exporters to Europe, North America, and parts of the Middle East.
China, in particular, has ramped up its (6-Aminohexyl)carbamic acid production capacities in response to growing international orders. In 2023, China accounted for over 40% of the global export volume, mainly shipping to Germany, the United States, and Japan. With competitive pricing and flexible production capabilities, Chinese producers have maintained a dominant position in the global supply chain.
India follows as a prominent exporter, although its role has been more focused on supplying to emerging economies and select markets in Africa and Southeast Asia. Indian companies benefit from cost-effective labor and moderate regulatory oversight, though environmental compliance remains a concern. However, domestic demand is also rising, especially with the country focusing on pharmaceutical self-reliance, slightly curbing its export capacity.
On the import side, the United States remains one of the largest buyers of (6-Aminohexyl)carbamic acid. The U.S. pharmaceutical and biotech sectors heavily rely on specialty intermediates sourced from Asia due to lower costs and stable supply. In 2024, the U.S. imported approximately 8,000 MT of the compound, mainly for R&D and drug manufacturing processes.
European countries, particularly Germany, the Netherlands, and the UK, also exhibit strong import demand. Their preference leans toward high-purity and certified variants of the product, sourced primarily from compliant manufacturing units in China and Japan. Environmental regulations in the EU have made domestic production more costly, thus incentivizing imports over local manufacturing.
Japan and South Korea, while capable of producing (6-Aminohexyl)carbamic acid locally, also engage in selective imports to supplement specialized production needs or meet urgent demand surges. Their exports mostly cater to Southeast Asian markets and, occasionally, Australia and New Zealand.
In terms of export revenue, the global (6-Aminohexyl)carbamic acid sales volume reached an estimated 28,000 MT in 2024, with a total export market value of approximately $85 million. The consistent demand in pharma, coatings, and advanced material industries is likely to keep trade volumes high throughout 2025.
A notable development in 2025 has been the increased scrutiny of cross-border chemical movements. With international regulations tightening around hazardous chemical transport, exporters are facing additional compliance obligations. This includes updated safety data sheets, certification of origin, and cargo tracking. These measures, while enhancing safety, have marginally increased the cost and time required for global shipments.
Another key trend is the regionalization of trade, where nearby countries prefer sourcing (6-Aminohexyl)carbamic acid from regional producers. For instance, Southeast Asian countries have begun sourcing more from India and Malaysia to avoid long lead times and reduce freight charges from China. Similarly, Latin America has started to explore sourcing partnerships with U.S.-based distributors and Mexican chemical companies.
Efforts toward supply chain diversification are also visible. Major buyers, particularly in Europe and North America, are exploring long-term supply agreements with multiple suppliers across regions to mitigate risks associated with geopolitical instability or shipping disruptions.
Technological innovation in packaging and bulk transport, such as improved corrosion-resistant containers and controlled environment logistics, is further streamlining the import-export processes. These advances have enhanced shelf-life and purity retention, increasing confidence among buyers dealing with long-distance shipments.
With continued demand growth and evolving regulatory frameworks, the global (6-Aminohexyl)carbamic acid import-export ecosystem is becoming more sophisticated. Exporters are adapting through investments in quality assurance, certification, and digital tracking systems, while importers are focusing on securing diversified, reliable, and cost-effective supply chains.
The (6-Aminohexyl)carbamic acid news from 2025 highlights significant developments, including the commissioning of new production units in Southeast Asia, upgrades in logistics management in European ports, and the integration of AI-driven demand forecasting by leading U.S.-based buyers.
As trade volumes grow and international standards become stricter, the emphasis on sustainability and traceability is shaping a more resilient and transparent trade environment for (6-Aminohexyl)carbamic acid.
For a detailed report and data on (6-Aminohexyl)carbamic acid price news, production volumes, import-export statistics, and market share by region, visit the full coverage here:
👉 https://datavagyanik.com/reports/6-aminohexylcarbamic-acid-market-size-production-sales-average-product-price-market-share-import-vs-export/
Request your sample now to explore the latest (6-Aminohexyl)carbamic acid news and market insights.
(6-Aminohexyl)carbamic acid Production Trends by Geography
The global production of (6-Aminohexyl)carbamic acid is concentrated across several key regions, with Asia-Pacific, North America, and Europe being the primary contributors. These regions collectively account for the majority of global output due to their advanced chemical manufacturing infrastructure, access to raw materials, and strong downstream demand. Over the years, regional production trends have been shaped by regulatory frameworks, cost dynamics, technological advancement, and shifting consumption patterns.
Asia-Pacific
Asia-Pacific dominates the production landscape of (6-Aminohexyl)carbamic acid, with China and India emerging as the two leading countries. China, with its expansive chemical parks and integrated supply chains, has become a global supplier of this compound. Chinese producers benefit from economies of scale, domestic raw material availability, and a favorable cost environment. In 2025, Chinese manufacturers continue to expand production capacity to meet increasing global demand, especially from pharmaceutical and specialty chemical sectors.
India, on the other hand, is becoming an increasingly important producer due to its growing domestic demand and supportive policy environment. The government’s push to strengthen the pharmaceutical sector under various initiatives has led to increased local production of intermediates like (6-Aminohexyl)carbamic acid. Indian firms are also emphasizing higher-purity grades suitable for export markets. The ability to offer custom synthesis at competitive prices makes India a strong player in the international supply chain.
South Korea and Japan also contribute significantly to production, albeit at smaller volumes. These countries emphasize high-quality manufacturing, often targeting niche segments requiring ultra-pure grades. Their production facilities are technologically advanced and compliant with global regulatory standards, making them preferred suppliers for European and North American buyers seeking premium quality.
North America
In North America, the United States leads the production of (6-Aminohexyl)carbamic acid. American chemical companies are primarily focused on producing this compound for domestic consumption in pharmaceutical R&D and high-end industrial applications. The production in the U.S. is driven by a mix of in-house manufacturing and contract manufacturing organizations (CMOs) serving biotech and pharmaceutical clients.
Although the cost of production is higher in the U.S. compared to Asia, the focus remains on producing superior-quality materials under stringent regulatory control. Innovation in synthesis processes and automated production systems has helped U.S. producers remain competitive. Furthermore, there is a growing trend of reshoring critical chemical production, including compounds like (6-Aminohexyl)carbamic acid, to reduce dependency on imports and strengthen supply chain security.
Europe
Europe has a well-established but moderately sized (6-Aminohexyl)carbamic acid production base. Germany is at the forefront, with its robust chemical and pharmaceutical sectors. German firms emphasize sustainable production and compliance with EU environmental regulations. Despite higher operational costs, European producers maintain a reputation for precision and quality, catering to demand in life sciences, coatings, and advanced materials.
France, the Netherlands, and Belgium also contribute to regional production. However, increasing environmental regulations and high labor costs are compelling some European companies to shift or outsource production to Asian partners while retaining product development and quality oversight domestically.
Latin America and Middle East
While Latin America has not been a major producer, Brazil is gradually developing capabilities in specialty chemical manufacturing. Investments in this sector are largely driven by domestic demand in pharmaceuticals and agriculture. Similarly, the Middle East, particularly Saudi Arabia, is beginning to invest in specialty chemicals as part of its diversification strategy. However, both regions currently contribute minimally to global output.
Africa
Africa remains on the periphery of (6-Aminohexyl)carbamic acid production. The continent’s limited infrastructure and lack of skilled chemical manufacturing labor restrict large-scale production activities. However, certain North African countries are evaluating partnerships with Asian firms to establish regional production hubs to serve local demand.
Summary
In 2025, the production of (6-Aminohexyl)carbamic acid is marked by a combination of cost-driven manufacturing in Asia and quality-focused production in the West. Regional specialization, compliance frameworks, and trade relations play a central role in shaping output patterns. Asia-Pacific continues to expand capacity, North America emphasizes innovation and quality, and Europe maintains a balance between regulation and production efficiency. The overall trend is toward securing stable supply chains and enhancing sustainable production across all major regions.
(6-Aminohexyl)carbamic acid Market Segmentation
Market Segmentation Points:
- By Application
- Pharmaceuticals
- Chemical Intermediates
- Biotechnology
- Specialty Coatings
- Research & Development
- By End-User Industry
- Pharmaceutical Companies
- Chemical Manufacturers
- Academic and Research Institutions
- Biotechnology Firms
- Industrial Manufacturing
- By Purity Level
- Standard Grade
- High Purity Grade
- Ultra-High Purity Grade
- By Distribution Channel
- Direct Sales
- Distributors
- Online Chemical Marketplaces
- By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
Explanation on Leading Segments
The (6-Aminohexyl)carbamic acid market is highly segmented based on diverse application needs and quality standards. Each segment reflects different consumption behavior, pricing sensitivities, and regulatory requirements, which in turn influence production and distribution strategies.
Application-Based Segmentation
The pharmaceutical sector is the most dominant application segment for (6-Aminohexyl)carbamic acid. The compound serves as a critical intermediate in the synthesis of several APIs (Active Pharmaceutical Ingredients) and advanced intermediates. Its structural compatibility and functional group profile make it suitable for a range of chemical reactions, boosting its demand in both bulk drug and specialty drug manufacturing. As pharmaceutical R&D expands globally, this segment continues to lead in both volume and value.
The chemical intermediates segment is also significant. In this domain, (6-Aminohexyl)carbamic acid is used in complex organic syntheses, resins, and performance materials. With the growth in advanced polymers and specialty chemicals, demand for intermediates with functional diversity is increasing, supporting the growth of this segment.
The biotechnology sector is an emerging application area where this compound is used in peptide modification, drug delivery research, and enzyme-linked applications. Its compatibility with biomolecules and customizable purity levels make it suitable for highly controlled research environments.
The specialty coatings segment is another growing area where (6-Aminohexyl)carbamic acid is used as a functional additive. It enhances adhesion and chemical resistance in coatings used in electronics, medical devices, and aerospace components.
End-User Industry Segmentation
Pharmaceutical companies represent the largest end-user group. With their high reliance on consistent quality and traceable supply chains, they drive demand for certified, high-purity variants of the compound. As regulatory scrutiny increases, this group is increasingly sourcing from compliant suppliers with strong quality assurance systems.
Chemical manufacturers use the product as part of their intermediate synthesis chains. They often seek bulk quantities at competitive prices and may accept lower purity grades depending on the downstream use. These buyers are highly sensitive to price trends and supply availability.
Academic and research institutions use (6-Aminohexyl)carbamic acid in small quantities for method development and exploratory research. Their demand, while limited in volume, is crucial for developing next-generation applications and testing new compound derivations.
Biotechnology firms are fast-growing consumers, using this compound in experimental formulations, delivery systems, and diagnostics. Their focus is on innovation and quality, often requiring small but highly controlled batches.
Purity Level Segmentation
Standard-grade (6-Aminohexyl)carbamic acid is mostly used in industrial and bulk chemical applications where high-end purity is not critical. This grade is more affordable and produced in larger quantities.
High-purity grade is commonly used in pharmaceutical and biotech applications where the compound must meet strict regulatory and safety standards. This segment commands a price premium and demands meticulous quality control.
Ultra-high purity grade is a niche segment catering to critical drug development and high-end biotech research. Although volumes are low, the profitability is high due to the value-added nature of the applications.
Distribution Channel Segmentation
Direct sales dominate the supply to large pharmaceutical and chemical companies that prefer to deal directly with certified manufacturers for quality assurance and volume discounts.
Distributors play an important role in servicing small- to mid-sized enterprises and research institutions. They provide flexibility in batch size and often hold ready inventory for faster deliveries.
Online chemical marketplaces are a growing distribution channel, enabling researchers and small businesses to source compounds easily. These platforms offer a range of grades and lot sizes, increasing accessibility and market penetration.
Regional Segmentation
Asia-Pacific is the leading region in terms of production and sales volume. Demand is driven by local pharmaceutical manufacturing and exports to Europe and North America.
North America follows, with its mature pharmaceutical and biotech sectors driving steady demand for high-grade compounds. Regional sourcing preferences and reshoring initiatives are adding to demand stability.
Europe remains a quality-focused region, with regulatory compliance being the primary driver of supplier selection. High-value demand is prominent in Germany, France, and Switzerland.
Other regions like Latin America and the Middle East are witnessing slow but steady growth, mainly driven by pharmaceutical infrastructure development and increased research funding.